Literature DB >> 6263317

Regulation or procollagen messenger ribonucleic acid levels in Rous sarcoma virus transformed chick embryo fibroblasts.

M R Sobel, T Yamamoto, B de Crombrugghe, I Pastan.   

Abstract

Using cloned cDNAs for pro-alpha 1 and pro-alpha 2 collagen messenger ribonucleic acid (mRNA), we have investigated the regulation of collagen mRNA levels in Rous sarcoma virus (RSV) transformed chick embryo fibroblasts (CEF). We find that both pro-alpha 1 and pro-alpha 2 mRNA levels are decreased approximately 10-fold in CEF transformed by either the Bryan high-titer strain or the Schmidt-Ruppin strain of RSV. Using temperature-sensitive mutants in the transforming gene src, we also investigated the rate of change in the levels of the two mRNA species. We employed mutants of both the Bryan high-titre strain (BHTa) and the Schmidt-Ruppin strain (ts68). With both mutants the results were similar. Upon shift from the permissive temperature (35 degrees C) to the non-permissive temperature (41 degrees C), collagen mRNA synthesis, did not increase until more than 5 h had passed, suggesting that action of src on collagen gene expression is indirect. Upon shift from 41 to 35 degrees C, collagen mRNA levels fell with a half-life of 10 h. Whether this fall reflects the half-life of procollagen mRNA or an effect of src on procollagen RNA stability is unclear. Both pro-alpha 1 and pro-alpha 2 mRNA levels were coordinately controlled.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6263317     DOI: 10.1021/bi00512a049

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  22 in total

1.  Regulation of collagen I gene expression by ras.

Authors:  J L Slack; M I Parker; V R Robinson; P Bornstein
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

2.  Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin.

Authors:  U M Wewer; L A Liotta; M Jaye; G A Ricca; W N Drohan; A P Claysmith; C N Rao; P Wirth; J E Coligan; R Albrechtsen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Extracellular-matrix synthesis by skeletal muscle in culture. Major secreted collagenous proteins of clonal myoblasts.

Authors:  R L Beach; J S Rao; B W Festoff
Journal:  Biochem J       Date:  1985-02-01       Impact factor: 3.857

4.  Control of types I and II collagen and fibronectin gene expression in chondrocytes delineated by viral transformation.

Authors:  E S Allebach; D Boettiger; M Pacifici; S L Adams
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

Review 5.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

6.  Regulation of type VI collagen synthesis in transformed mesenchymal cells.

Authors:  T Schreier; R R Friis; K H Winterhalter; B Trüeb
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

7.  Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.

Authors:  S A Jimenez; G Feldman; R I Bashey; R Bienkowski; J Rosenbloom
Journal:  Biochem J       Date:  1986-08-01       Impact factor: 3.857

8.  Type I collagen formation in rat type II alveolar cells immortalised by viral gene products.

Authors:  R Matsui; R H Goldstein; K Mihal; J S Brody; M P Steele; A Fine
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

9.  Tumor-promoting phorbol esters inhibit procollagen synthesis at a pretranslational level in JB-6 mouse epidermal cells.

Authors:  M E Sobel; L D Dion; J Vuust; N H Colburn
Journal:  Mol Cell Biol       Date:  1983-08       Impact factor: 4.272

10.  Stimulation of alpha 1 (I) procollagen gene expression in NIH-3T3 cells by the human T cell leukemia virus type 1 (HTLV-1) Tax gene.

Authors:  E Muñoz; D Suri; S Amini; K Khalili; S A Jiménez
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.